[1] WANG W,JIANG B,SUN H,et al.Prevalence,incidence,and mortality of stroke in china:results from a nationwide population-based survey of 480687 adults[J].Circulation,2017,135(8):759-771.
[2] WANG Y,ZHAO X,LIU L,et al.Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China:The Chinese Intracranial Atherosclerosis (CICAS) Study[J].Stroke,2014,45(3):663-669.
[3] BALOCH Z W,HARRELL R M,BRETT E M,et al.American association of clinical endocrinologists and american college of endocrinology disease state commentary:Managing thyroid tumors diagnosed as noninvasive follicular thyroid neoplasm with papillary-like nuclear features[J].Endocr Pract,2017,23(9):1150-1155.
[4] 冯燕娴,石增刚,汤凤英,等.血清载脂蛋白B、载脂蛋白B/载脂蛋白A1值与冠状动脉病变的相关性分析[J].东南大学学报(医学版),2011,30(4):577-580.
[5] HAUSER P S,NARAYANASWAMI V,RYAN R O.Apolipoprotein E:From lipid transport to neurobiology[J].Prog Lipid Res,2011,50(1):62-74.
[6] GU L,SU L,CHEN Q,et al.Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations:New data and meta-analysis[J].Exp Ther Med,2013,5(3):853-859.
[7] 中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[8] JR A H,BENDIXEN B H,KAPPELLE L J,et al.Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment[J].Stroke,1993,24(1):35-41.
[9] WENHAM P R,PRICE W H,BLANDELL G.Apolipoprotein E typing by one-stage PCR[J].Lancet,1991,337(8750):1158-1159.
[10] MAHLEY R W,RALL S J.Apolipoprotein E:Far more than a lipid transport protein[J].Annu Rev Genomics Hum Genet,2000,1:507-537.
[11] BALLARD C G,MORRIS C M,RAO H,et al.APOE epsilon 4 and cognitive decline in older stroke patients with early cognitive impairment[J].Neurology,2004,63(8):1399.
[12] BEISIEGEL U,WEBER W,IHRKE G,et al.The LDL receptor related protein,LRP,is an apolipoprotein E-binding protein[J].Nature,1989,341(6238):162-164.
[13] BIFFI A,ANDERSON C D,JAGIELLA J M,et al.APOE genotype predicts extent of bleeding and outcome in lobar intracerebral hemorrhage[J].Lancet Neurol,2011,10(8):702.
[14] MARTÍNEZGONZLEZ N A,SUDLOW C L M.Effects of apolipoprotein E genotype on outcome after ischaemic stroke,intracerebral haemorrhage and subarachnoid haemorrhage[J].J Neuro Neurosur Psy,2006,77(12):1329-1335.
[15] 刘岩峰,黄平,何欣,等.ApoE的研究进展及其在脑外伤发生中的意义[J].证据科学,2007,14(1):72-75.
[16] 张斌,陈伟,张嵘,等.中国人载脂蛋白e基因多态性与轻度认知功能损害关系的meta分析[J].东南大学学报(医学版),2015,34(1):83-87.
[17] MCCARRON M O,DELONG D,ALBERTS M J.APOE genotype as a risk factor for ischemic cerebrovascular disease:A meta-analysis[J].Neurology,1999,53(6):1308-1311.
[18] HORSBURGH K,KELLY S,MCCULLOCH J,et al.Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia[J].Neuroreport,1999,10(4):837-841.
[19] SHENG H,LASKOWITZ D T,MACKENSEN G B,et al.Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse[J].Stroke,1999,30(5):1118-1124.
[20] MCCOLL B W,MCGREGOR A L,WONG A,et al.APOE epsilon 3 gene transfer attenuates brain damage after experimental stroke[J].J Cereb Blood Flow Metab,2007,27(3):477-487.
[21] GUO L,LADU M J,VAN ELDIK L J.A dual role for apolipoprotein e in neuroinflammation:Anti-and pro-inflammatory activity[J].J Mol Neurosci,2004,23(3):205-212.
[22] ALPÉROVITCH A,KURTH T,BERTRAND M,et al.Primary prevention with lipid lowering drugs and long term risk of vascular events in older people:Population based cohort study[J].BMJ,2015,350:h2335.
[23] FULCHER J,O'CONNELL R,VOYSEY M,et al.Efficacy and safety of LDL-lowering therapy among men and women:Meta-analysis of individual data from 174,000 participants in 27 randomised trials[J].Lancet,2015,385(9976):1397-1405.
[24] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,16(10):15-35.
[25] VITALI C,KHETARPAL S A,RADER D J.HDL cholesterol metabolism and the risk of CHD:New insights from human genetics[J].Curr Cardiol Rep,2017,19(12):132.
[26] MIYATA M,SMITH J D.Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides-Nature Genetics[J].Nat Genet,1996:51-62.
[27] CATTO A J,MCCORMACK L J,MANSFIELD M W,et al.Apolipoprotein E polymorphism in cerebrovascular disease[J].Acta Neurol Scand,2000,101(6):399.
[28] GROMADZKA G,BARANSKA GIERUSZCZAK M,SARZYNSKA DLUGOSZ I,et al.The APOE polymorphism and 1-year outcome in ischemic stroke:genotype-gender interaction[J].Acta Neurol Scand,2007,116(6):392-398.
[29] WEIR C J,MCCARRON M O,MUIR K W,et al.Apolipoprotein E genotype,coagulation,and survival following acute stroke[J].Neurology,2001,57(6):1097-1100.
[30] TREGER I,FROOM P,RING H,et al.Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients[J].Arch Phys Med Rehab,2003,84(7):973-976. |